Ginsenoside Rb1 directly scavenges hydroxyl radical and hypochlorous acid

Current Pharmaceutical Design

Volumn 18, Issue 38, 2012, Pages 6339-6347

  Lü, Jian Ming ^a   Weakley, Sarah M ^a   Yang, Zhen ^b   Hu, Ming ^b   Yao, Qizhi ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Antioxidant; Cell free system; DNA plasmid; Ginsenoside Rb1; HOCl; Hydroxyl radical; Superoxide anion

Indexed keywords

GINSENOSIDE RB 1; HYDROGEN; HYDROXYL RADICAL; HYPOCHLOROUS ACID; PLASMID DNA; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TYROSINE;

ARTICLE; ATOM; CHEMICAL BOND; CHLORINATION; DRUG EFFECT; LIQUID CHROMATOGRAPHY; OXIDATIVE STRESS; PRIORITY JOURNAL;

CELL-FREE SYSTEM; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; GINSENOSIDES; HYDROXYL RADICAL; HYPOCHLOROUS ACID; MASS SPECTROMETRY; OXIDATION-REDUCTION; OXIDATIVE STRESS; TYROSINE;

EID: 84873958897     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212803832254     Document Type: Article

References (63)

1. Vajragupta O, Boonchoong P, Berliner LJ. Manganese complexes of curcumin analogues: evaluation of hydroxyl radical scavenging ability, superoxide dismutase activity and stability towards hydrolysis. Free Radic Res 2004; 38(3): 303-14.
2. Lü JM, Lin PH, Yao Q, Chen C. Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med 2010; 14(4): 840-60.
3. Ames BN, Gold LS. Endogenous mutagens and the causes of aging and cancer. Mutat Res 1991; 250(1-2): 3-16.
4. Ames BN, Shigenaga MK, Gold LS. DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis. Environ Health Perspect 1993; 101 Suppl 5: 35-44.
5. Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology 2006; 13(3): 171-81.
6. Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat Res 1995; 339(2): 73-89.
7. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27: 229-65.
8. Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature 2012; 481(7381): 278-86.
9. Zitvogel L, Kepp O, Galluzzi L, Kroemer G. Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 2012; 13(4): 343-51.
10. Conforti-Andreoni C, Ricciardi-Castagnoli P, Mortellaro A. The inflammasomes in health and disease: from genetics to molecular mechanisms of autoinflammation and beyond. Cell Mol Immunol 2011; 8(2): 135-45.
11. Rathinam VA, Vanaja SK, Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol 2012; 13(4): 333-2.
12. Wen H, Ting JP, O'Neill LA. A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation? Nat Immunol 2012; 13(4): 352-7.
13. Franchi L, Munoz-Planillo R, Nunez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 2012; 13(4): 325-32.
14. DeFeudis FV, Papadopoulos V, Drieu K. Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol 2003; 17(4): 405-17.
15. Hercberg S, Galan P, Preziosi P, et al. The SU. VI. MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004; 164(21): 2335-42.
16. Kirsh VA, Hayes RB, Mayne ST, et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 2006; 98(4): 245-54.
17. Lin J, Cook NR, Albert C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 2009; 101(1): 14-23.
18. Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2009; 301(1): 52-62.
19. Heaney ML, Gardner JR, Karasavvas N, et al. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res 2008; 68(19): 8031-8.
20. Lü JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 2009; 7(3): 293-302.
21. Blumenthal M. Herb sales down in mainstream market, up in natural food stores. Herbalgram 2002; 55: 60.
22. Cheng Y, Shen LH, Zhang JT. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 2005; 26(2): 143-9.
23. Dharmananda S. The nature of ginseng: traditional use, modern research, and the question of dosage. HerbalGram 2002; 54: 34-51.
24. Ohashi R, Yan S, Mu H, et al. Effects of homocysteine and ginsenoside Rb1 on endothelial proliferation and superoxide anion production. J Surg Res 2006; 133(2): 89-94.
25. Wang X, Chai H, Lin PH, Yao Q, Chen C. Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells. Am J Pathol 2009; 174(3): 771-81.
26. Kang KS, Kim HY, Baek SH, et al. Study on the hydroxyl radical scavenging activity changes of ginseng and ginsenoside-Rb2 by heat processing. Biol Pharm Bull 2007; 30(4): 724-8.
27. Floriano-Sanchez E, Villanueva C, Medina-Campos ON, et al. Nordihydroguaiaretic acid is a potent in vitro scavenger of peroxynitrite, singlet oxygen, hydroxyl radical, superoxide anion and hypochlorous acid and prevents in vivo ozone-induced tyrosine nitration in lungs. Free Radic Res 2006; 40(5): 523-33.
28. Lapenna D, Cuccurullo F. Hypochlorous acid and its pharmacological antagonism: an update picture. Gen Pharmacol 1996; 27(7): 1145-7.
29. Medina-Campos ON, Barrera D, Segoviano-Murillo S, et al. Sallylcysteine scavenges singlet oxygen and hypochlorous acid and protects LLC-PK(1) cells of potassium dichromate-induced toxicity. Food Chem Toxicol 2007; 45(10): 2030-9.
30. Bou R, Codony R, Tres A, Decker EA, Guardiola F. Determination of hydroperoxides in foods and biological samples by the ferrous oxidation-xylenol orange method: a review of the factors that influence the method's performance. Anal Biochem 2008; 377(1): 1-15.
31. Ak T, Gulcin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact 2008; 174(1): 27-37.
32. Dairam A, Fogel R, Daya S, Limson JL. Antioxidant and ironbinding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. J Agric Food Chem 2008; 56(9): 3350-6.
33. Zhao F, Liu ZQ, Wu D. Antioxidative effect of melatonin on DNA and erythrocytes against free-radical-induced oxidation. Chem Phys Lipids 2008; 151(2): 77-84.
34. Ramoutar RR, Brumaghim JL. Effects of inorganic selenium compounds on oxidative DNA damage. J Inorg Biochem 2007; 101(7): 1028-35.
35. Carr AC, Tijerina T, Frei B. Vitamin C protects against and reverses specific hypochlorous acid-and chloramine-dependent modifications of low-density lipoprotein. Biochem J 2000; 346 Pt 2: 491-9.
36. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998; 92(9): 3007-17.
37. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39(1): 44-84.
38. Neeb P. Structure-Reactivity Based Estimation of the Rate Constants for Hydroxyl Radical Reactions with Hydrocarbons. J Atmospheric Chem 2000; 35: 295-315.
39. Bektasoglu B, Esin Celik S, Ozyurek M, Guclu K, Apak R. Novel hydroxyl radical scavenging antioxidant activity assay for watersoluble antioxidants using a modified CUPRAC method. Biochem Biophys Res Commun 2006; 345(3): 1194-200.
40. Cederbaum AI, Dicker E, Cohen G. Effect of hydroxyl radical scavengers on microsomal oxidation of alcohols and on associated microsomal reactions. Biochemistry 1978; 17(15): 3058-64.
41. Spasojevic I, Mojovic M, Blagojevic D, et al. Relevance of the capacity of phosphorylated fructose to scavenge the hydroxyl radical. Carbohydr Res 2009; 344(1): 80-4.
42. Kang KS, Yokozawa T, Yamabe N, Kim HY, Park JH. ESR study on the structure and hydroxyl radical-scavenging activity relationships of ginsenosides isolated from Panax ginseng C A Meyer. Biol Pharm Bull 2007; 30(5): 917-21.
43. Boosalis MG. The role of selenium in chronic disease. Nutr Clin Pract 2008; 23(2): 152-60.
44. Schnabel R, Lubos E, Messow CM, et al. Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. Am Heart J 2008; 156(6): 1201 e1-11.
45. Pitt AR, Spickett CM. Mass spectrometric analysis of HOCl-and free-radical-induced damage to lipids and proteins. Biochem Soc Trans 2008; 36(Pt 5): 1077-82.
46. Mohiuddin I, Chai H, Lin PH, et al. Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res 2006; 133(2): 143-9.
47. Maier KL, Matejkova E, Hinze H, et al. Different selectivities of oxidants during oxidation of methionine residues in the alpha-1-proteinase inhibitor. FEBS Lett 1989; 250(2): 221-6.
48. Washida D, Kitanaka S. Determination of polyacetylenes and ginsenosides in Panax species using high performance liquid chromatography. Chem Pharm Bull 2003; 51(11): 1314-7.
49. Xu QF, Fang XL, Chen DF. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J Ethnopharmacol 2003; 84(2-3): 187-92.
50. Lau WS, Chan RY, Guo DA, Wong MS. Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway. J Steroid Biochem Mol Biol 2008; 108(1-2): 64-71.
51. Leung KW, Cheung LW, Pon YL, et al. Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor. Br J Pharmacol 2007; 152(2): 207-15.
52. Leung KW, Leung FP, Mak NK, et al. Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells. Br J Pharmacol 2009; 156(4): 626-37.
53. Papapetropoulos A. A ginseng-derived oestrogen receptor beta (ERbeta) agonist, Rb1 ginsenoside, attenuates capillary morphogenesis. Br J Pharmacol 2007; 152(2): 172-4.
54. Leung KW, Leung FP, Huang Y, Mak NK, Wong RN. Nongenomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor. FEBS Lett 2007; 581(13): 2423-8.
55. Yu J, Eto M, Akishita M, et al. Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor. Biochem Biophys Res Commun 2007; 353(3): 764-9.
56. Dawson DW, Volpert OV, Gillis P, et al. Pigment epitheliumderived factor: a potent inhibitor of angiogenesis. Science 1999; 285(5425): 245-8.
57. Ho TC, Chen SL, Yang YC, Liao CL, Cheng HC, Tsao YP. PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. Cardiovasc Res 2007; 76(2): 213-23.
58. Guan M, Pang CP, Yam HF, Cheung KF, Liu WW, Lu Y. Inhibition of glioma invasion by overexpression of pigment epitheliumderived factor. Cancer Gene Ther 2004; 11(5): 325-32.
59. Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991; 53(3): 411-4.
60. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 2005; 41(5): 861-8.
61. Chai H, Yang H, Yan S, et al. Effects of 5 HIV protease inhibitors on vasomotor function and superoxide anion production in porcine coronary arteries. J Acquir Immune Defic Syndr 2005; 40(1): 12-9.
62. Chen C, Chai H, Wang X, et al. Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood 2008; 112(8): 3205-16.
63. Chen C, Jiang J, Lü JM, et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 2010; 299(1): H193-201.